Clinical Trial Update: Mgso4 as Neuroprotective in Post Traumatic Brain Injury [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating magnesium sulfate as a neuroprotective treatment after traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Osama Mohamed Abdelwahab | Conditions: Magnesium Sulphate, Traumatic Brain Injury | Phase 3 | Status: COMPLETED